Key themes and emerging questions in regulation.
Amélie Chollet | CMS
Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.
Key themes and emerging questions in regulation.
Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.